Low Risk Differentiated Thyroid Cancer: Clinical Trials

1 trial for Low Risk Differentiated Thyroid Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Active not recruiting 1

Follow Low Risk Differentiated Thyroid Cancer: new trials by email Literature Review of Low Risk Differentiated Thyroid Cancer trials Research Report on Low Risk Differentiated Thyroid Cancer

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?
rhTSH stimulation, I131, Follow up - Low Risk Differentiated Thyroid Cancer
Phase 3Active not recruitingGustave Roussy, Cancer Campus, Grand Paris7762013-05-132023-05-17

Interventions

Iodine-131 (1)  ·  Thyrotropin Alfa (1)

Sponsors

Gustave Roussy, Cancer Campus, Grand Paris (1)

Countries

France (1)

Results publications

PMID 35263518, PMID 39586309